SEARCH RESULTS FOR:
Kerry Knoll
EXECUTIVE CHAIRMAN, GENERATION MINING
"This powerline goes right over the Marathon property, allowing us to make use of the grid, which only has a 4% carbon footprint. We will thus be producing some of the cleanest palladium worldwide."
Gary O’Connor
CEO & CHIEF GEOLOGIST, MONETA GOLD (TSX: ME | OTCQX: MEAUF)
Moneta Gold speaks with GBR about their project Tower Gold
Adrian Duhalt
POST-DOCTORATE FELLOW – MEXICAN ENERGY STUDIES, BAKER INSTITUTE
Adrian Duhalt analyzes Mexico’s petrochemical sector and future industry trends.
Jorge Buckup
PRESIDENT – LATIN AMERICA, UNIVAR SOLUTIONS
Latin America Petrochemicals and Chemicals 2021 - Digital Interactive
Univar Solutions explains its digital strategy and focus on sustainability.
Rich Nolan
PRESIDENT AND CEO, NATIONAL MINING ASSOCIATION
The National Mining Association explains how the US is encouraging mining in order to ensure national demand for in critical minerals as well as traditional metals.
Steve Cochrane
US SALES MANAGER, CYANCO
Newfoundland and Labrador Mining 2021
Cyanco is a world leader in production, distribution and safe handling of high-quality solution and solid sodium cyanide based in Nevada.
Greg Rickford
MINISTER OF NORTHERN DEVELOPMENT, MINES, NATURAL RESOURCES, FORESTRY AND INDIGENOUS AFFAIRS, GOVERNMENT OF ONTARIO
Greg Rickford, Ontario’s Minister for Natural Resources and Forestry, explains what his government is doing to promote the mining sector and how it can benefit the province.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
